Patents
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
05/2004
05/13/2004US20040092518 Compounds for the treatment of metabolic disorders
05/13/2004US20040092516 Insulin resistance; antidiabetic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders
05/12/2004CN1495542A Electric photographic photoreceptor, imaging processing cartidge and electric photographic device
05/11/2004US6734154 Contacting the substrate with a mono-, di-, or trialkoxy-substituted perfluoroalkane, perfluorocycloalkane, or perfluorocycloalkyl(ene)- containing perfluoroalkane
05/06/2004WO2004037768A2 Phenethanolamine derivatives
05/06/2004WO2004037226A2 Pharmaceutical compositions containing venlafaxine
05/06/2004WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/06/2004US20040087747 Acrylic polymers containing pendant primary carbamate groups, a method of making said polymers, and curable coating compositions containing said polymers
05/06/2004US20040087715 For use as topcoats on automobiles; improved wear/etch resistance
05/06/2004US20040087650 Inhibitors of IMPDH enzyme
05/06/2004US20040087632 Controlling metabolism of lipids, cholesterol
05/06/2004US20040087620 Terphenyl compounds bearing substituted amino groups
05/06/2004US20040087590 Novel biphenyl and biphenyl-like cannabinoids
05/06/2004US20040084653 Aromatic diamine derivatives, the preparation thereof and alignment film materials containing same for liquid crystal display cell
05/06/2004US20040083855 Antimisting agents
05/06/2004EP1415979A1 Process for the preparation of polyalkylphenoxyaminoalkanes
05/06/2004EP1414783A1 Method for the production of amines by reductive amination of carbonyl compounds under transfer-hydrogenation conditions
05/06/2004EP1140826B1 Method for producing (2s,4r,9s)-octahydro-1h-indole-2-carboxylic acid and intermediate products therefor
05/06/2004CA2503380A1 Pharmaceutical compositions containing venlafaxine
05/05/2004CN1494564A Oxalkylation products produced from expoxides and amines and their use in pigment preparations
05/05/2004CN1494526A Inhibitor of monoamine uptake
05/05/2004CN1148343C Process for preparing carboxylic acids
05/02/2004WO2004011400A1 Method of deuterating aromatic ring
04/2004
04/29/2004WO2004035534A2 Novel compounds having a dopaminergic and/or serotoninergic activity
04/29/2004WO2004006354A3 Polymeric charge transport compositions and electronic devices made with such compositions
04/29/2004US20040082796 Reacting a substituted benzonitrile with a cysteine compound
04/29/2004US20040082754 Novel aromatic diamine and polyimide thereof
04/29/2004US20040082666 Antiserotonine agents
04/29/2004US20040082625 Osteoporosis, bone disorders
04/29/2004DE10248925A1 Neue Verbindungen mit dopaminerger und/oder serotoninerger Aktivität New connections with dopaminergic and / or serotonergic activity
04/29/2004CA2501990A1 Cationic cardiolipin analogs and use thereof
04/28/2004EP1412555A1 Corrosion inhibitors with improved water solubility and improved film persistence
04/28/2004EP1412343A1 New compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias
04/28/2004EP1412321A2 Perfluoroalkyl-substituted amines, acids, amino acids and thioether acids
04/28/2004EP1411898A1 Pharmaceutical composition comprising lipids with a polar and a nonpolar moiety
04/28/2004EP1263715B1 Novel phenylheteroalkylamine derivatives
04/28/2004EP1263714B1 Novel phenylheteroalkylamine derivatives
04/28/2004EP1154983B1 Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
04/28/2004CN1147461C 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof
04/28/2004CN1147460C Method for preparing high purity low E type tamoxifen or its citrate
04/28/2004CN1147459C Galcium receptor-active compound
04/27/2004US6727379 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for production thereof
04/27/2004US6727255 Brain, nervous system and psychological disorders
04/22/2004WO2004033412A1 Novel beta mimetics with extended duration of action, method for production and use thereof as medicaments
04/22/2004WO2003057164A3 Compounds for delivering substances into cells
04/22/2004US20040077896 Compounds for the treatment of metabolic disorders
04/22/2004US20040077867 Amine compounds, their production and use
04/22/2004US20040077860 Quinoxaline derivative; light-emitting diode, light-emitting electrochemical cell, or a photodetector
04/22/2004CA2501055A1 Novel betamimetics with extended duration of action, method for production and use thereof as medicaments
04/21/2004EP1208077B1 2-hydroxy-5-amino-biphenyl-derivatives and oxidative hair colouring agents containing said compounds
04/21/2004CN1146410C Controlled release formulation
04/20/2004US6723753 Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
04/20/2004US6723752 (R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
04/20/2004US6723749 Treating bacterial infections
04/20/2004US6723731 3-(4-(2-(5h-dibenzo(a,d)cyclohepten-5-yloxy)-ethoxyl-phenyl)-2 -ethoxy-propionic acid ethyl ester as antidiabetic agents and to treat obesity
04/20/2004US6723343 Pharmaceutical tramadol salts
04/15/2004WO2004031125A1 Spiro compounds, medicinal compositions containing the same and intermediates of the compounds
04/15/2004WO2003061552A3 Novel process for the preparation of substantially pure 5-(3,5-dimethylphenoxy)methyl-2-oxazolidinone
04/15/2004US20040073054 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups
04/15/2004US20040072868 Liver disorders; anticholesterol agents; cardiovascular disorders
04/15/2004US20040072854 Antiemetics; psychlogical disorders; antidepressants; anxiolytic agents; antitussive agents
04/15/2004DE10246374A1 New 4-(2-alkylamino-1-hydroxyethyl)-3-alkoxy-benzene-1,2-diol derivatives, are beta-mimetics having a long duration of action, useful e.g. for treating asthma, chronic obstructive pulmonary disease or arrhythmia
04/15/2004CA2500869A1 Spiro compounds, medicinal compositions containing the same and intermediates of the compounds
04/14/2004EP1406577A1 Novel coupler components for oxidative hair colouring
04/14/2004EP1019361B1 Polyfunctional cationic cytofectins, formulations and methods for generating active cytofectin:polynucleotide transfection complexes
04/14/2004EP0724561B1 Calcium receptor-active arylalkyl amines
04/14/2004CN1145606C 2-aminotetrahydronaphthalene, process for their preparation, and pharmaceutical composition for prevention and therapeutic treatment of in flammatory and lor autoimmune pathologies
04/13/2004US6720323 Colchinol derivatives as angiogenesis inhibitors
04/08/2004WO2004028451A2 β-HYDROXYPHENYLALKYLAMINES AND THEIR USE FOR TREATING GLAUCOMA
04/08/2004WO2003103609A3 Novel trifluoromethylepinephrine compounds and methods of making and using thereof
04/08/2004WO2003097622A3 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof
04/08/2004WO2003084919A3 Method for preparing combretastatins
04/08/2004WO2003076386A3 Catalysts and method for the production of amines
04/08/2004US20040068131 Production of novel phosphane ligands and use in catalytical reactions
04/08/2004US20040068115 Charge transport compositions and electronic devices made with such compositions
04/08/2004US20040067927 Substituted alkyldiamines
04/08/2004US20040066135 Electronic devices made with electron transport and/or anti-quenching layers
04/08/2004CA2492468A1 .beta.-hydroxyphenylalkylamines and their use for treating glaucoma
04/07/2004EP1405843A1 Method for producing aminostilbene derivative
04/07/2004EP1175389B1 Process for the production of etheramine alkoxylates
04/07/2004EP1086077B1 Novel antiestrogens, a method for the production thereof, and their pharmaceutical application
04/07/2004CN1487821A Novel couplers for use in oxidative hair dyeing
04/07/2004CN1487819A Primary intermediate for oxidative coloration of hair
04/07/2004CN1487818A Primary intermediates for oxidative coloration of hair
04/07/2004CN1487817A Primary intermediates for oxidative coloration of hair
04/06/2004US6717015 Venlafaxine besylate
04/06/2004US6717013 Easily attained with high positional selectivity and yield; intermediates and raw materials
04/06/2004US6716882 Highly packed polycationic ammonium, sulfonium and phosphonium lipids
04/06/2004CA2359061C Crystal polymorphism of aminoethylphenoxyacetic acid derivative
04/01/2004WO2004027788A1 Nonaqueous electrolyte, electrical double layer capacitors, and nonaqueous electrolyte secondary cells
04/01/2004WO2004026817A1 Amino alcohol derivative, addition salt thereof, and immunosuppressant
04/01/2004WO2004026815A2 Phenol derivatives and their use as rotamase inhibitors
04/01/2004WO2004026807A1 Intermediates in producing phenoxyacetic acid derivatives and method of using the same
04/01/2004WO2004006352A3 Electronic devices made with electron transport and/or anti-quenching layers
04/01/2004WO2003101932A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
04/01/2004WO2003095415A3 Aminated compounds bearing at least an allyl and a difluoromethyl and method used for synthesis thereof
04/01/2004US20040063760 Sodium channel modulatiors
04/01/2004US20040063755 Aromatic compounds containing hydroxyalkylaminoalkylphenylaminophenyl group; useful for treating pre-term labor, neurological disorders and cardiac disorders
04/01/2004CA2499185A1 Nonaqueous electrolyte, electrical double-layer capacitors, and nonaqueous electrolyte secondary cells
04/01/2004CA2498662A1 Phenol derivatives and their use as rotamase inhibitors
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 140